Zacks Investment Research Lowers H. B. Fuller Company (FUL) to Sell

H. B. Fuller Company (NYSE:FUL) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a research note issued on Monday, June 5th.

According to Zacks, “H.B. Fuller Company is a worldwide manufacturer and marketer of adhesives, sealants, coatings, paints and other specialty chemical products. The company’s largest worldwide business category is adhesives, sealants and coatings. These products are sold to customers in a wide range of industries, including packaging, woodworking, automotive, aerospace, graphic arts (books/magazines), appliances, filtration, windows, sporting goods, nonwovens, shoes and ceramic tile. “

Separately, Citigroup Inc. raised their target price on shares of H. B. Fuller Company from $55.00 to $59.00 and gave the stock a “buy” rating in a research note on Tuesday, April 4th. One analyst has rated the stock with a sell rating, three have assigned a hold rating and two have issued a buy rating to the company’s stock. The company has a consensus rating of “Hold” and a consensus target price of $52.40.

Shares of H. B. Fuller Company (NYSE:FUL) opened at 51.08 on Monday. H. B. Fuller Company has a one year low of $41.52 and a one year high of $54.32. The company has a 50-day moving average price of $51.84 and a 200 day moving average price of $50.44. The firm has a market capitalization of $2.58 billion, a P/E ratio of 21.85 and a beta of 1.65.

H. B. Fuller Company (NYSE:FUL) last announced its quarterly earnings results on Wednesday, March 29th. The specialty chemicals company reported $0.48 EPS for the quarter, beating analysts’ consensus estimates of $0.45 by $0.03. The firm had revenue of $503.32 million during the quarter, compared to analysts’ expectations of $485.17 million. H. B. Fuller Company had a net margin of 5.65% and a return on equity of 13.81%. During the same quarter last year, the company posted $0.43 earnings per share. Analysts expect that H. B. Fuller Company will post $2.66 earnings per share for the current fiscal year.

ILLEGAL ACTIVITY NOTICE: This piece of content was originally posted by Sports Perspectives and is the property of of Sports Perspectives. If you are accessing this piece of content on another domain, it was illegally copied and republished in violation of US and international trademark and copyright legislation. The correct version of this piece of content can be read at https://sportsperspectives.com/2017/06/22/hb-fuller-co-ful-stock-rating-lowered-by-zacks-investment-research-updated-updated.html.

In other H. B. Fuller Company news, VP David W. Moorman sold 1,683 shares of the firm’s stock in a transaction dated Monday, May 1st. The shares were sold at an average price of $52.76, for a total value of $88,795.08. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Also, VP Steven Kenny sold 7,000 shares of the firm’s stock in a transaction dated Friday, March 31st. The shares were sold at an average price of $52.50, for a total transaction of $367,500.00. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 13,866 shares of company stock worth $716,760. 3.10% of the stock is owned by insiders.

Large investors have recently bought and sold shares of the stock. Mairs & Power INC increased its stake in H. B. Fuller Company by 0.4% in the third quarter. Mairs & Power INC now owns 3,540,296 shares of the specialty chemicals company’s stock worth $164,518,000 after buying an additional 13,770 shares during the last quarter. Barrow Hanley Mewhinney & Strauss LLC increased its stake in H. B. Fuller Company by 8.6% in the fourth quarter. Barrow Hanley Mewhinney & Strauss LLC now owns 124,485 shares of the specialty chemicals company’s stock worth $6,014,000 after buying an additional 9,897 shares during the last quarter. Comerica Bank increased its stake in H. B. Fuller Company by 10.7% in the fourth quarter. Comerica Bank now owns 254,857 shares of the specialty chemicals company’s stock worth $12,794,000 after buying an additional 24,608 shares during the last quarter. Dimensional Fund Advisors LP increased its stake in H. B. Fuller Company by 4.0% in the fourth quarter. Dimensional Fund Advisors LP now owns 1,924,186 shares of the specialty chemicals company’s stock valued at $92,958,000 after buying an additional 74,558 shares in the last quarter. Finally, Martingale Asset Management L P increased its stake in H. B. Fuller Company by 30.3% in the fourth quarter. Martingale Asset Management L P now owns 14,621 shares of the specialty chemicals company’s stock valued at $707,000 after buying an additional 3,400 shares in the last quarter. Institutional investors own 93.71% of the company’s stock.

About H. B. Fuller Company

H.B. Fuller Company is a formulator, manufacturer and marketer of adhesives, sealants and other specialty chemical products. The Company’s segments include Americas Adhesives, Europe, India, Middle East and Africa (EIMEA), Asia Pacific, Construction Products and Engineering Adhesives. The Americas Adhesives, EIMEA and Asia Pacific operating segments produce and supply industrial adhesives products for applications in various markets, including durable assembly, nonwoven and hygiene, and textile.

Get a free copy of the Zacks research report on H. B. Fuller Company (FUL)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for H. B. Fuller Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for H. B. Fuller Company and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply